AFR today 24 mins ago – 11.56AMRhinomed charges ahead on COVID tests dealTom RichardsonRhinomed shares are up 15 per cent to 44¢ this morning after it announced the Victorian government has ordered an initial 1 million ‘Rhinoswabs’ to assist it with COVID-19 testing.The ‘Rhinoswab’ is a nasal test for COVID-19 that works in conjunction with PCR workflows.It said the revenue associated with the order equals around 35 per cent to 45 per cent of financial 2021 revenues of $3.9 million.
RNO Price at posting:
43.5¢ Sentiment: Buy Disclosure: Held